CASEY CRUMB: Open Payments
NPI 1700225646 · PELL CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,034 in 42 payments from 15 companies in 2025. Trend: 2023 $1,372 · 2024 $1,327 · 2025 $1,034
Food & beverage: $1,034
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $408 |
| GlaxoSmithKline, LLC. | 11 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $66 |
| Novo Nordisk Inc | 3 | $56 |
| Lilly USA, LLC | 3 | $52 |
| SHIELD THERAPEUTICS INC | 2 | $48 |
| Abbott Laboratories | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $31 |
| Corium, LLC | 1 | $23 |
| Esperion Therapeutics, Inc. | 1 | $21 |
Products named: REPATHA, TRELEGY ELLIPTA, OTEZLA, JARDIANCE, ACCRUFER, FREESTYLE LIBRE 3, EVENITY, Ozempic.
Industry payments across AL — which companies pay providers there.
